# US 2021/0087207 A1 · Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0087207 A1
- Document ID: US20210087207A1
- Status: Published application
- Kind: A1
- Application number: 16/610,186
- Filed: 2018-05-02
- Published: 2021-03-25
- Earliest claimed: 2017-05-03
- Assignees: BASF SE
- Applicants: BASF SE
- Inventors: Harish SHINDE; Christopher KORADIN; Joachim DICKHAUT; Roland GOETZ; Eric George KLAUBER; Sukunath NARAYANAN; Dhanyakumar RAUT
- Web page: https://patentgrep.com/patent/US20210087207A1

## CPC

- C07D 513/04: Ortho-condensed systems
- C07C 403/04: having side-chains substituted by halogen atoms
- C07D 277/32: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07D 419/04: directly linked by a ring-member-to-ring-member bond
- C07B 2200/07: Optical isomers
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to a process for preparing optically active compounds of formula X and intermediates thereof, wherein the variables of compound of formula X are as defined in the claims and the description.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim at position 2

16: A process for preparing S-containing pyrimidinium compound of formula X
wherein
C* is an asymmetric carbon atom of S or R-configuration;
R1 is C1-C4-alkyl, C3-C6-cycloalkyl, C2-C4-alkenyl, or —CH2-phenyl, which groups are unsubstituted or substituted with halogen or C1-C4-alkyl;
R2 is a 5- or 6-membered saturated, partially unsaturated or aromatic carbo- or heterocyclic ring, wherein the ring is unsubstituted or substituted with R2a;
Het is selected from D-1, D-2, and D-3:
wherein
Ra is each independently Ra is halogen, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, or phenyl;
n is 0, 1 or 2; and
# denotes the bond in formula X;
R2a is halogen, C1-C6-haloalkyl, C1-C6-haloalkoxy, ORc, C(═O)ORc, C(═O)NRbRc, phenyl, or pyridyl, which is unsubstituted or substituted with halogen, C1-C6-haloalkyl or C1-C6-haloalkoxy;
Rb is hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy;
Rc is hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C6 cycloalkyl;
wherein two geminally bound groups RcRb together with the atom to which they are bound, may form a 3- to 7-membered saturated, partially unsaturated or aromatic heterocyclic ring;
comprising at least the step of,
(E) reacting the compound of formula VII,
wherein
C* is an asymmetric carbon atom of S or R-configuration;
Het is as defined in compound of formula X;
with R1NCS, wherein R1 is C1-C4-alkyl, C3-C6-cycloalkyl, C2-C4-alkenyl or —CH2-phenyl, which groups unsubstituted or substituted by halogen or C1-C4-alkyl;
in the presence of a base,
to obtain a compound of formula VIII,
wherein
C* and Het are as defined in the compound of formula VII;
R1 is as defined herein.

### Claim at position 3 (depends on 1, 16)

17: The process according to claim 16, further comprising at least the steps of,
(A) reacting a compound of formula III,
wherein
W is halogen, O-p-toluenesulfonyl, O-methanesulfonyl, or O-trifluoromethanesulfonyl;
Het is as defined in compound of formula X in claim 1;
with M2ORAC wherein M2 is selected from lithium, sodium, potassium, aluminium, barium, caesium, calcium, and magnesium; RAC is C(═O)—C1-C4-alkyl;
to obtain the compound of formula IV,
wherein Het and RAC are as defined herein;
(B) hydrolyzing the compound of formula IV as defined herein in the presence of an acid or a base to obtain a compound of formula V,
wherein Het is as defined in compound of formula IV;
(C) reacting the compound of formula V with X2SO2NH2 wherein X2 is halogen, to obtain the compound of formula VI
wherein Het is as defined in compound of formula V;
(D) hydrogenation of the compound of formula VI,
in the presence of a hydrogenation catalyst MXLn(η-arene)m
wherein
M is a transition metal from group VIII to group XII of the periodic table;
X is an anion;
m is 0 or 1;
Ln is Ln1 or Ln2,
wherein
Ln1 is a chiral ligand of the formula Ln1,
wherein
C* is an asymmetric carbon atom of S or R-configuration;
R10 is OH or NH—SO2—R11;
R11 is aryl unsubstituted or substituted independently of each other with halogen, C1-C10-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, or SO3Na;
or
R11 is C1-C10-perfluoroalkyl, or R13R14N wherein R13 and R14 independently represent C1-C10-alkyl unsubstituted or substituted with C6-C10-aryl, or R13 and R14 each independently represent a C6-C10-cycloalkyl;
R12 independently represents aryl ring or C6-C10-cycloalkyl ring, wherein the ring is unsubstituted or substituted independently of each other with halogen, C1-C10-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, or SO3Na, or both R12 are linked together to form a 3- to 6-membered carbocyclic ring or a 5- to 10-membered partially unsaturated carbocyclic ring;
Ln2 is a chiral phosphorous ligand;
and a hydrogen source selected from a)hydrogen, b) mixture of N(R)3 wherein R is H or C1-C6-alkyl, and HCOOH, c) HCOONa or HCOOK, d) mixture of C1-C8-alcohol and t-BuOK, t-BuONa, or t-BuOLi, and e) combination of two or more from a) to d);
to obtain a compound of formula VII,
wherein
C* is an asymmetric carbon atom of S or R-configuration;
Het is as defined in compound of formula VI.

### Claim at position 4 (depends on 16)

18: The process according to claim 16, further comprising the step (F) of reacting the compound of formula VIII with a compound of formula IX,
wherein,
LG is a leaving group selected from halogen, ORu, and SRu; wherein
Ru is C1-C6-alkyl or aryl, which is unsubstituted or substituted with halogen;
R2 is a 5- or 6-membered saturated, partially unsaturated or aromatic carbo- or heterocyclic ring, wherein the ring is unsubstituted or substituted with R2a;
to obtain the compound of formula X.

### Claim at position 5 (depends on 17)

19: The process according to claim 17, wherein η-arene is aryl ring which is unsubstituted or substituted with C1-C4-alkyl.

### Claim at position 6 (depends on 17)

20: The process according to claim 17, wherein q-arene is selected from benzene, p-cymene, mesitylene, 1,3,5-triethylbenzene, hexamethylbenzene, anisole, 1,5-cyclooctadiene, cyclopentadienyl (Cp), norbornadiene, and pentamethylcyclopentadienyl (Cp*).

### Claim at position 7 (depends on 17)

21: The process according to claim 17, wherein MXLn(η-arene)m in step (D) is MXLn1(η-arene)m and wherein R10 is NH—SO2—R11; and R12 and R11 independently are phenyl which are unsubstituted or substituted with 1 or 2 substituents selected from halogen, C1-C4-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, and SO3Na.

### Claim at position 8 (depends on 17)

22: The process according to claim 17, wherein MXLn(η-arene)m in step (D) is MXLn1(η-arene)m and wherein X is halide; R12 independently is phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl or 4-methoxyphenyl; R10 is NH—SO2—R11 and —SO2—R11 is p-toluenesulfonyl, methanesulfonyl, 4-benzenesulfonyl, or pentafluorophenyl-sulfonyl.

### Claim at position 9 (depends on 17)

23: The process according to claim 17, wherein m is 1 and MXLn(η-arene)m in step (D) is of the formula MXLnCp*, wherein M is rhodium, ruthenium, iridium, palladium, iron, platinum, or nickel.

### Claim at position 10 (depends on 17)

24: The process according to claim 17, wherein M in step (D) is rhodium, ruthenium, or iridium.

### Claim at position 11 (depends on 16)

25: The process according to claim 16, wherein the base in step (E) is selected from triethylamine, diisopropylethyl amine, tri-nbutylamine, sodium hydroxide, and potassium hydroxide.

### Claim at position 12 (depends on 16)

26: The process according to claim 16, wherein
R1 is C1-C4-alkyl, C3-C6-cycloalkyl, or C2-C4-alkenyl, which is unsubstituted, or substituted with halogen.

### Claim at position 13 (depends on 16)

27: The process according to claim 16, wherein
R2 is phenyl, pyridinyl, or thiophenyl, which is unsubstituted or substituted by R2a.

### Claim at position 14 (depends on 16)

28: The process according to claim 16, wherein
Ra is halogen or C1-C4-haloalkyl.

### Claim at position 15 (depends on 16)

29: The process according to claim 16, wherein Het is D-2 wherein n is 0 and Ra is halogen.

### Claim at position 16 (depends on 16)

30: An optically active compound of formula VII
wherein
C* is an asymmetric carbon atom of S or R-configuration;
and wherein Het is D-2 or D-3 as defined in claim 16.
